Efficacy of Tecarfarin Mirrors Earlier Studies While Primary Endpoint Missed FREMONT, Calif.--(BUSINESS WIRE)--Jul 8, 2009 - ARYx Therapeutics, Inc. (NASDAQ:ARYX), a biopharmaceutical company, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback